DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Steppich B, Dobler F, Brendel LC. et al.
Effect of the FXa inhibitors rivaroxaban and apixaban on platelet activation in patients with atrial fibrillation.
J Thromb Thrombolysis 2017;
43 (04) 490-497
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.